News & Announcements

Asuragen Announces CE Mark of AmplideX® SMA Plus Kit

July 7th, 2020|

The assay is intended to aid in the diagnosis of and identification of carriers for spinal muscular atrophy (SMA) AUSTIN, Texas--(BUSINESS WIRE)-- Asuragen, Inc., a molecular diagnostics company delivering easy-to-use products for complex testing in genetics and oncology, today announced CE Mark of [...]

Magstim Acquires Electrical Geodesics, Inc. (EGI) Product Portfolio

July 2nd, 2020|

High-density EEG complements Magstim’s Transcranial Magnetic Stimulation Technology Driving Innovation MINNEAPOLIS, Minn. & Carmarthenshire, UK — (July 2, 2020) – Magstim, the global leader in Transcranial Magnetic Stimulation (TMS), today announced an agreement to acquire the product portfolio [...]

Specific Diagnostics Announces that NIAID has Awarded the Company a Further $2.9 million for the Commercial Development of the Reveal Rapid Antibiotic Susceptibility Testing (AST) System

June 2nd, 2020|

MOUNTAIN VIEW, California, June 2, 2020  – Specific Diagnostics today announces that the National Institute for Allergy and Infectious Disease (NIAID) has awarded a second major grant to drive the commercial introduction of Specific’s Reveal system, which provides quantitative determination of antib [...]